stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G/A - Aclaris Therapeutics, Inc. | StockGist | StockGist
Companies
ACRS
SCHEDULE 13G/A
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
ACRS
SCHEDULE 13G/A
SCHEDULE 13G/A
Beneficial Ownership
Amendment
Aclaris Therapeutics, Inc.
Filed Jan 21, 2026
Accepted Jan 20, 2026, 7:00 PM ET
ACRS
CIK 0001557746
View on SEC.gov
Company Profile
0002012383-26-000630
Beneficial Ownership Report
Passive Investment
Reporting Person
Aclaris Therapeutics, Inc.
Person Type
HC
CUSIP: 00461U105
Amendment History
4 filings
SCHEDULE 13G
Original
Jul 29, 2025
0000932471-25-000787
SCHEDULE 13G/A
Amendment 1
Jan 9, 2026
0000929638-26-000098
SCHEDULE 13G/A
Amendment 2
Viewing
Jan 21, 2026
0002012383-26-000630
SCHEDULE 13G/A
Amendment 3
Latest
Mar 26, 2026
0000102909-26-000505